Sage Moon Bioscience (SMB) is a 501(c) nonprofit (NPO) research organization specializing in the development of novel non-toxic Cancer/Human Disease Vaccines.
Our mission is to END global Cancer/Human Disease...Today.
SMB has completed research and synthesis of a generic version (SMB-308) of HU-308 at 99.9% less cost. HU-308 is a Cannabinoid Cell Receptor 2 (CB2) ligand that is very similar to Anandamide. It is a research ligand compound that is patented to Professor Raphael Mechoulam. CB2 Cell Receptor ligands are non-toxic and have "tremendous potential for treatment and prevention (vaccine) of most human oxidative diseases including Cancer, HIV, Alzheimer's Disease, Autism, CFS, and Heart Disease." (US National Institutes of Health) It is this critical non-toxic CB2 cellular pathway that is the key to a novel therapeutic cellular target (neuromodulators) for treatment and prevention (vaccine) of Cancer and most human diseases.
Tocris Bioscience is a leading manufacturer/supplier of research pharmaceuticals (like HU-308) to the NIH:
The National Institutes of Health (NIH) is an agency of the United States Department of Health and Human Services and is the primary agency of the United States government responsible for biomedical and health-related research. It is the largest Medical Research Organization in the world.
Every human and most living species have an Endocannabinoid System (ECS) that was incredibally only discovered in 1992 by Professor Raphael Mechoulam. (NIH Researcher) This ECS human cellular protective system is 600 million years old and controls most human (cellular) functions. (appetite, mood, memory, pain, etc) All 100 trillion cells in the human body have Cannabinoid Cell Receptors. We have only discovered Cannabinoid Cell Receptor 1 (CB1 in 1988) and CB2 (1992) Cell Receptors. CB3 is the "orphan" cell receptor GPR55 protein cell receptor. Recently discovered, the nucleus is not the "brain" of the human cell; instead, the cell membrane is actually the brain of the human cell. The nucleus is actually the reproductive (cell division) part of the human cell. (Bruce Lipton: NIH Cell Biologist) This is critical because Cannabinoid Cell Receptors are located on cell membranes. Cannabinoids and the Endocannabinoid System tell the human cell "brain" what to do, including cell death in Cancer by Natural Killer (NK) Cell activation. (CB2 Receptors are incredibally located on NK Cells) That means that the brain of the human cell is receiving (DNA) information from external sources. This external source is Cannabinoids. Cannabinoids tell the human cell what to do. We also produce naturally two (and counting) Endocannabinoids (endogenous) called Anandamide and 2AG. (1992/1995: Professor Raphael Mechoulam) Anandamide's discovery ends the debate of Cannabinoid's medical significance. HUMANS PRODUCE CANNABINOIDS (ANANDAMIDE AND 2AG) NATURALLY. This is the medical discovery of the century. A natural human cellular protective system that regulates all human functions (appetite, mood, memory, pain, etc) that was incredibally only discovered in 1992. Modern Medicine will forever be changed for the better by CB2 Cellular targeted novel therapeutics like HU-308. Remember, HU-308 is a pharmacuetical molecular copy of the naturally produced, Anandamide. Anandamide regulates human functions like: Pain, Memory, Mood, Appetite, Sleep, Digestion, Kidney, Liver, Cardiovascular, CNS, NK cells, ETC.
The key is CB2 Cell Receptor activation at potency levels of 5000X. At these cellular membrane (brain of the cell) sites, there is no toxicity or side effects. CB1 Cell Receptor modulation is the culprit due to it's toxicity and side effects which limit CB2 Cell Receptor modulation. This will allow for super potent dosages up to 1000 mg/day without any toxicity or side effects. Toxicity and side effects (pychoactivity) is the most important issue, for it prevents a patient from receiving increased CB2 receptor modulation.
US Patent 6,630,507 was funded and researched by our United States National Institutes of Health. It is the largest Medical Research Organization on the planet. This patent was then awarded and assigned to the United States of America as represented by the Department of Health and Human Services on October 7, 2003. The patent states that "the invention (CANNABINOIDS) is treatment and prevention (vaccine) for most human diseases including Cancer, Arthritis, Diabetes, and Hepatitis." The United States of America patented the cure/vaccine for all human diseases including Cancer on October 7, 2003. Humans (Cellular) have naturally produced endogenous Cannabinoids (Endocannabinoids) for over 600 million years and it was incredibally only discovered in 1992 by Professor Raphael Mechoulam. This is the most significant medical discovery in human history. It will forever change medical research and cellular-targeted therapeutics.
The first Cannabinoid was discovered in 1942 by NIH Researcher Roger Adams. This medical miracle was patented on December 8, 1942: US Patent #2,304,669.
This story's time has come. Please help us by contacting local leaders in health, politics, law, religion, education, commerce, and media. But, most of all, please let your friends and family know healing is here...now. We just need to spread the cure.
Peter Moon, Founder/CEO
Sage Moon Bioscience
The National Cancer Institute is the US government's Cancer Research organization. It only spends 4% of it's yearly budget on Pediatric (Childhood) Cancer Research. Children with Cancer need our Voice to help raise awareness and funding. Please watch/share the video below from childhood Cancer patients hosted by Melinda Marchiano: